SEATTLE, Feb. 13, 2018 (GLOBE NEWSWIRE) — Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the development of universal, off-the-shelf cell therapies to treat cancer and other critical diseases, today announced the initiation of its Phase 2 LAUNCH clinical trial. The open-label, multi-center, randomized, controlled, dose-finding LAUNCH trial will evaluate Nohla’s lead […]
This post first appeared on Bloggerwave Inc. Is In The StockGuru Spotlight For October 22, 2010 | StockGuru SmallCap Alerts On Penny Stocks, please read the originial post: here
